Press releasePRNewswire
vVARDIS Holding AG
VVVV · NYSE
$16.50+$16.50 (+0.00%)TodayMarket closed ·
Prev close $0.00
VVVV key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- —
- Volume
- 3.78M
- Open price
- $14.00
- High today
- $16.94
- Low today
- $14.00
- 52 Week high
- —
- 52 Week low
- —
vVARDIS Holding AG (VVVV) at a glance
As of Nov 13, 2026, vVARDIS Holding AG (VVVV) shares are priced at $16.50.
Today the stock has traded between $14.00 and $16.94. The current price is 17.9% above the day's low and 2.6% below its high.
VVVV news
- Press releasePRNewswire
Weekly Gains Hold Up Despite a Friday Slide as Chips Lead and Yields Climb
- Press releasePRNewswire
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
- Press releaseBusiness Wire
vVARDIS Announces Pricing of Initial Public Offering
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+17.65%
- SHFSSHF Holdings$0.0303+34.67%
- NVDANVIDIA$162.85−2.01%
- TIPSTianrong Internet Products & Services$0.0006+50.00%
- ZBAOZhibao Technology$0.2794+32.54%
- SOXLDirexion Shares ETF Trust$58.32−10.99%
- ONFOOnfolio Holdings$0.7745+128.87%
- AITXArtificial Intelligence Technology Solutions$0.0003+0.00%
- NUNu Holdings$13.22+11.75%
- HADVHealth Advance$0.0003+0.00%
- PARAParabolic Technologies$0.107+6.26%
- RAINRain Enhancement Technologies Holdco$0.7499+58.31%
Newly listed
Companies that went public in the past six weeks
- NARANarragansett Bancorp$10.60+0.33%
- ASPEAspen Neuroscience$12.59−7.49%
- BBTXBambusa Therapeutics$16.09−3.94%
- GBCGEORGIA BANKING$34.11−1.84%
- BHAIUBHAV Acquisition Corp II$10.01−0.06%
- SCQCUSPACCircle Acquisition$10.01−0.10%
- LYCALycia Therapeutics$31.20−4.96%
- DAVIDAVION HEALTHCARE$1.00−15.97%
- TCXBTCGX Acquisition Corp. II$10.25+0.89%
- CTYCITY THERAPEUTICS$18.10−4.64%
- IAMIambic Therapeutics$13.10−11.73%
- AMROAmaero$5.50−14.06%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.